Condensed Consolidating Statement of Cash Flows (Details) (USD $) | 9 Months Ended |
In Thousands, unless otherwise specified | Oct. 04, 2014 | Oct. 05, 2013 |
Condensed Cash Flow Statements, Captions [Line Items] | ' | ' |
Net Cash Provided by (Used in) Operating Activities | $540,294 | $398,467 |
Purchases of property and equipment | -161,542 | -147,690 |
Business acquisitions, net of cash acquired | -2,060,816 | -187,211 |
Proceeds from Sale of Property, Plant, and Equipment | 710 | 723 |
Net cash used in investing activities | -2,221,648 | -317,380 |
Increase (decrease) in bank overdrafts | 3,366 | -8,665 |
Borrowings under credit facilities | 1,940,700 | 0 |
Payments on credit facilities | -1,258,400 | 0 |
Dividends paid | -17,561 | -17,563 |
Proceeds from the issuance of common stock, primarily exercise of stock appreciation rights | 5,506 | 3,609 |
Tax withholdings related to the exercise of stock appreciation rights | -4,730 | -20,572 |
Excess tax benefit from share-based compensation | 5,698 | 15,168 |
Repurchase of common stock | -839 | -78,637 |
Contingent consideration related to previous business acquisition | -10,047 | -4,726 |
Other | -801 | -511 |
Net Cash Provided by (Used in) Financing Activities | 662,892 | -111,897 |
Effect of Exchange Rate on Cash and Cash Equivalents | -4,345 | 0 |
Net increase (decrease) in cash and cash equivalents | -1,022,807 | -30,810 |
Cash and cash equivalents, beginning of period | 1,112,471 | 598,111 |
Cash and cash equivalents, end of period | 89,664 | 567,301 |
Parent Company [Member] | ' | ' |
Condensed Cash Flow Statements, Captions [Line Items] | ' | ' |
Net Cash Provided by (Used in) Operating Activities | 0 | ' |
Purchases of property and equipment | 0 | ' |
Business acquisitions, net of cash acquired | 0 | ' |
Proceeds from Sale of Property, Plant, and Equipment | 0 | ' |
Net cash used in investing activities | 0 | ' |
Increase (decrease) in bank overdrafts | 0 | ' |
Borrowings under credit facilities | 0 | ' |
Payments on credit facilities | 0 | ' |
Dividends paid | 0 | ' |
Proceeds from the issuance of common stock, primarily exercise of stock appreciation rights | 0 | ' |
Tax withholdings related to the exercise of stock appreciation rights | 0 | ' |
Excess tax benefit from share-based compensation | 0 | ' |
Repurchase of common stock | 0 | ' |
Contingent consideration related to previous business acquisition | 0 | ' |
Other | 0 | ' |
Net Cash Provided by (Used in) Financing Activities | 0 | ' |
Effect of Exchange Rate on Cash and Cash Equivalents | 0 | ' |
Net increase (decrease) in cash and cash equivalents | 0 | ' |
Cash and cash equivalents, beginning of period | 9 | ' |
Cash and cash equivalents, end of period | 9 | ' |
Guarantor Subsidiaries [Member] | ' | ' |
Condensed Cash Flow Statements, Captions [Line Items] | ' | ' |
Net Cash Provided by (Used in) Operating Activities | 521,116 | ' |
Purchases of property and equipment | -159,621 | ' |
Business acquisitions, net of cash acquired | -2,059,986 | ' |
Proceeds from Sale of Property, Plant, and Equipment | 692 | ' |
Net cash used in investing activities | -2,218,915 | ' |
Increase (decrease) in bank overdrafts | 3,375 | ' |
Borrowings under credit facilities | 1,940,700 | ' |
Payments on credit facilities | -1,258,400 | ' |
Dividends paid | -17,561 | ' |
Proceeds from the issuance of common stock, primarily exercise of stock appreciation rights | 5,506 | ' |
Tax withholdings related to the exercise of stock appreciation rights | -4,730 | ' |
Excess tax benefit from share-based compensation | 5,698 | ' |
Repurchase of common stock | -839 | ' |
Contingent consideration related to previous business acquisition | -10,047 | ' |
Other | -801 | ' |
Net Cash Provided by (Used in) Financing Activities | 662,901 | ' |
Effect of Exchange Rate on Cash and Cash Equivalents | 0 | ' |
Net increase (decrease) in cash and cash equivalents | -1,034,898 | ' |
Cash and cash equivalents, beginning of period | 1,106,766 | ' |
Cash and cash equivalents, end of period | 71,868 | ' |
Non-Guarantor Subsidiaries [Member] | ' | ' |
Condensed Cash Flow Statements, Captions [Line Items] | ' | ' |
Net Cash Provided by (Used in) Operating Activities | 19,178 | ' |
Purchases of property and equipment | -1,921 | ' |
Business acquisitions, net of cash acquired | -830 | ' |
Proceeds from Sale of Property, Plant, and Equipment | 18 | ' |
Net cash used in investing activities | -2,733 | ' |
Increase (decrease) in bank overdrafts | 0 | ' |
Borrowings under credit facilities | 0 | ' |
Payments on credit facilities | 0 | ' |
Dividends paid | 0 | ' |
Proceeds from the issuance of common stock, primarily exercise of stock appreciation rights | 0 | ' |
Tax withholdings related to the exercise of stock appreciation rights | 0 | ' |
Excess tax benefit from share-based compensation | 0 | ' |
Repurchase of common stock | 0 | ' |
Contingent consideration related to previous business acquisition | 0 | ' |
Other | 0 | ' |
Net Cash Provided by (Used in) Financing Activities | 0 | ' |
Effect of Exchange Rate on Cash and Cash Equivalents | -4,345 | ' |
Net increase (decrease) in cash and cash equivalents | 12,100 | ' |
Cash and cash equivalents, beginning of period | 5,696 | ' |
Cash and cash equivalents, end of period | 17,796 | ' |
Consolidation, Eliminations [Member] | ' | ' |
Condensed Cash Flow Statements, Captions [Line Items] | ' | ' |
Net Cash Provided by (Used in) Operating Activities | 0 | ' |
Purchases of property and equipment | 0 | ' |
Business acquisitions, net of cash acquired | 0 | ' |
Proceeds from Sale of Property, Plant, and Equipment | 0 | ' |
Net cash used in investing activities | 0 | ' |
Increase (decrease) in bank overdrafts | -9 | ' |
Borrowings under credit facilities | 0 | ' |
Payments on credit facilities | 0 | ' |
Dividends paid | 0 | ' |
Proceeds from the issuance of common stock, primarily exercise of stock appreciation rights | 0 | ' |
Tax withholdings related to the exercise of stock appreciation rights | 0 | ' |
Excess tax benefit from share-based compensation | 0 | ' |
Repurchase of common stock | 0 | ' |
Contingent consideration related to previous business acquisition | 0 | ' |
Other | 0 | ' |
Net Cash Provided by (Used in) Financing Activities | -9 | ' |
Effect of Exchange Rate on Cash and Cash Equivalents | 0 | ' |
Net increase (decrease) in cash and cash equivalents | -9 | ' |
Cash and cash equivalents, beginning of period | 0 | ' |
Cash and cash equivalents, end of period | ($9) | ' |